Activated NF-κB initiates the transcription of pro-inflammatory genes, triggers and amplifies the inflammatory cascade response, directly disrupts the integrity of the BBB, and creates pathological conditions for HT [49–51]. The gene discussed is NFKB1; the disease is hematocrit.